Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.
Glial influence on the blood brain barrier.
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol.
Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells.
Intrinsic and extrinsic control of oligodendrocyte development.
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
Imaging of glutamate in the spinal cord using GluCEST.
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect.
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Imaging resting state brain function in multiple sclerosis.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Anti-drug antibodies: B-cell Immunity against therapy.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS).
Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture.
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).

Pages